BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 12458050)

  • 1. Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures.
    Mantegazza R; Bernasconi P; Baggi F; Spreafico R; Ragona F; Antozzi C; Bernardi G; Granata T
    J Neuroimmunol; 2002 Oct; 131(1-2):179-85. PubMed ID: 12458050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis.
    Rogers SW; Andrews PI; Gahring LC; Whisenand T; Cauley K; Crain B; Hughes TE; Heinemann SF; McNamara JO
    Science; 1994 Jul; 265(5172):648-51. PubMed ID: 8036512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis.
    Wiendl H; Bien CG; Bernasconi P; Fleckenstein B; Elger CE; Dichgans J; Mantegazza R; Melms A
    Neurology; 2001 Oct; 57(8):1511-4. PubMed ID: 11673604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune epilepsy: some epilepsy patients harbor autoantibodies to glutamate receptors and dsDNA on both sides of the blood-brain barrier, which may kill neurons and decrease in brain fluids after hemispherotomy.
    Ganor Y; Goldberg-Stern H; Amrom D; Lerman-Sagie T; Teichberg VI; Pelled D; Futerman AH; Zeev BB; Freilinger M; Verheulpen D; Van Bogaert P; Levite M
    Clin Dev Immunol; 2004; 11(3-4):241-52. PubMed ID: 15559370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-Targeted Autoimmune Sword in Fatal Epilepsy: Patient's glutamate receptor AMPA GluR3B peptide autoimmune antibodies bind, induce Reactive Oxygen Species (ROS) in, and kill both human neural cells and T cells.
    Levite M; Zelig D; Friedman A; Ilouz N; Eilam R; Bromberg Z; Ramadhan Lasu AA; Arbel-Alon S; Edvardson S; Tarshish M; Riek LP; Lako RL; Reubinoff B; Lebendiker M; Yaish D; Stavsky A; Galun E
    J Autoimmun; 2020 Aug; 112():102462. PubMed ID: 32561150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis.
    Watson R; Jiang Y; Bermudez I; Houlihan L; Clover L; McKnight K; Cross JH; Hart IK; Roubertie A; Valmier J; Hart Y; Palace J; Beeson D; Vincent A; Lang B
    Neurology; 2004 Jul; 63(1):43-50. PubMed ID: 15249609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmunity to the glutamate receptor in mice--a model for Rasmussen's encephalitis?
    Levite M; Hermelin A
    J Autoimmun; 1999 Aug; 13(1):73-82. PubMed ID: 10441170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies to the glutamate receptor kill neurons via activation of the receptor ion channel.
    Levite M; Fleidervish IA; Schwarz A; Pelled D; Futerman AH
    J Autoimmun; 1999 Aug; 13(1):61-72. PubMed ID: 10441169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rasmussen's encephalitis: an autoimmune disorder?
    Andrews PI; McNamara JO
    Curr Opin Neurobiol; 1996 Oct; 6(5):673-8. PubMed ID: 8937833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies and cell-mediated autoimmunity to NMDA-type GluRepsilon2 in patients with Rasmussen's encephalitis and chronic progressive epilepsia partialis continua.
    Takahashi Y; Mori H; Mishina M; Watanabe M; Kondo N; Shimomura J; Kubota Y; Matsuda K; Fukushima K; Shiroma N; Akasaka N; Nishida H; Imamura A; Watanabe H; Sugiyama N; Ikezawa M; Fujiwara T
    Epilepsia; 2005; 46 Suppl 5():152-8. PubMed ID: 15987271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic steroid-responsive encephalitis without autoantibodies to glutamate receptor GluR3.
    Krauss GL; Campbell ML; Roche KW; Huganir RL; Niedermeyer E
    Neurology; 1996 Jan; 46(1):247-9. PubMed ID: 8559386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamate receptor GluR3 antibodies and death of cortical cells.
    He XP; Patel M; Whitney KD; Janumpalli S; Tenner A; McNamara JO
    Neuron; 1998 Jan; 20(1):153-63. PubMed ID: 9459451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies to NMDA receptor in patients with chronic forms of epilepsia partialis continua.
    Takahashi Y; Mori H; Mishina M; Watanabe M; Fujiwara T; Shimomura J; Aiba H; Miyajima T; Saito Y; Nezu A; Nishida H; Imai K; Sakaguchi N; Kondo N
    Neurology; 2003 Oct; 61(7):891-6. PubMed ID: 14557555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to AMPA receptors in Rasmussen's encephalitis.
    Nibber A; Clover L; Pettingill P; Waters P; Elger CE; Bien CG; Vincent A; Lang B
    Eur J Paediatr Neurol; 2016 Mar; 20(2):222-227. PubMed ID: 26785913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rasmussen's encephalitis with concomitant cortical dysplasia: the role of GluR3.
    Palmer CA; Geyer JD; Keating JM; Gilliam F; Kuzniecky RI; Morawetz RB; Bebin EM
    Epilepsia; 1999 Feb; 40(2):242-7. PubMed ID: 9952274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rasmussen's syndrome.
    Granata T
    Neurol Sci; 2003 Oct; 24 Suppl 4():S239-43. PubMed ID: 14598051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.
    Dalmau J; Gleichman AJ; Hughes EG; Rossi JE; Peng X; Lai M; Dessain SK; Rosenfeld MR; Balice-Gordon R; Lynch DR
    Lancet Neurol; 2008 Dec; 7(12):1091-8. PubMed ID: 18851928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmunity to munc-18 in Rasmussen's encephalitis.
    Yang R; Puranam RS; Butler LS; Qian WH; He XP; Moyer MB; Blackburn K; Andrews PI; McNamara JO
    Neuron; 2000 Nov; 28(2):375-83. PubMed ID: 11144349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epilepsy and the immune system.
    Aarli JA
    Arch Neurol; 2000 Dec; 57(12):1689-92. PubMed ID: 11115234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.